{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:53:21Z","timestamp":1793408001562,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:sec id=\"ab-ooi250017-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>\n                      A subset of\n                      <jats:italic>Union for International Cancer Control<\/jats:italic>\n                      (\n                      <jats:italic>UICC<\/jats:italic>\n                      )\/\n                      <jats:italic>American Joint Committee on Cancer<\/jats:italic>\n                      (\n                      <jats:italic>AJCC<\/jats:italic>\n                      )\n                      <jats:italic>eighth edition<\/jats:italic>\n                      TNM stage I and II human papillomavirus\u2013positive oropharyngeal carcinoma has undesirable outcomes, which might have contributed to a lack of success in phase III deintensification trials. Refining clinical stage groups, especially in the overabundant cN1\/stage I group, has become important for treatment selection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ooi250017-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the prognostic importance of pretreatment lymph node (LN) characteristics to optimize case distribution and outcome homogeneity within the N classification system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ooi250017-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This is an international multi-institutional retrospective prognostic cohort study. Analysis of human papillomavirus\u2013positive oropharyngeal carcinoma treated curatively from 4 institutions (International Collaboration of Oropharyngeal Cancer Network for N-Classification [ICON-N] dataset) provided a refined clinical staging proposal; an independent dataset (Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al [CHUM] dataset) validated the proposal. Neuroradiologists reviewed pretreatment computed tomography and\/or magnetic resonance imaging for nodal features, including presence or absence of abnormal LN(s), retropharyngeal LN, laterality, number of abnormal LN, and imaging-detected extranodal extension (iENE). Data were collected from February to May 2023, and data were analyzed from June to July 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ooi250017-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Definitive chemoradiotherapy\/radiotherapy or definitive surgery with or without postoperative chemoradiotherapy\/radiotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ooi250017-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      The primary end point was overall survival. A Cox proportional hazards multivariable model was used to estimate adjusted hazard ratios (AHRs) and to derive an optimal clinical TNM stage classification (AHR-stage schema) incorporating the strongest prognostic nodal features within the\n                      <jats:italic>UICC\/AJCC eighth edition<\/jats:italic>\n                      TNM framework after confirming the prognostication of iENE status. The performance (according to overall normalized scores and ranking) of the AHR-stage schema against the current\n                      <jats:italic>UICC\/AJCC eighth edition<\/jats:italic>\n                      TNM staging system was evaluated for hazard consistency, hazard discrimination, prognostic importance, and sample size balance. Validation was performed in the CHUM dataset.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ooi250017-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The ICON-N dataset comprised 2053 patients, including 1898 (92.5%) with cN-positive disease and 155 (7.5%) with cN0 disease; a total of 298 (14.5%) were female, and the mean (SD) age was 60.6 (9.3) years. iENE-positive disease was identified in 710 of 1898 patients with cN-positive disease (37.4%). The median (range) follow-up was 5.1 (0.1-14.7) years. iENE was the strongest prognostic nodal feature in multivariable analysis; the AHR for iENE-positive vs iENE-positive disease was 2.43 (95% CI, 1.96-3.03) in the ICON-N dataset and 2.04 (95% CI, 1.28-3.23) in the CHUM dataset (n\u2009=\u2009451). Reclassifying iENE-positive cases 1 stratum higher for N categorization without altering iENE-negative cases yielded an AHR-stage schema that outperformed the current TNM staging system in disease-free and overall survival with a lower (ie, better) overall normalized score (2 vs 3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ooi250017-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this study, reclassifying each N category 1 stratum higher for iENE-positive disease resulted in better disease-free and overall survival. The proposed new classification outperformed the currently TNM staging system in risk stratification and may facilitate future clinical trial design, outcomes research, and patient care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaoto.2025.0848","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T11:00:35Z","timestamp":1746702035000},"page":"655","source":"Crossref","is-referenced-by-count":27,"title":["A Proposal for HPV-Associated Oropharyngeal Carcinoma in the Ninth Edition Clinical TNM Classification"],"prefix":"10.1001","volume":"151","author":[{"given":"Shao Hui","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo A.","family":"Koyfman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Routman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hoebers","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology (MAASTRO), GROW \u2013 School for Oncology and Reproduction, Maastricht University Medical Centre, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Bahig","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology and Head and Neck Imaging, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology and Head and Neck Imaging, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Spreafico","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lee","sequence":"additional","affiliation":[{"name":"Imaging Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stock","sequence":"additional","affiliation":[{"name":"Imaging Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil M.","family":"Woody","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoff","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Radiology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Lavigne","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc Felix","family":"Nguyen-Tan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"L\u00e9tourneau-Guillon","sequence":"additional","affiliation":[{"name":"Department of Radiology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Filion","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex A.","family":"Nagelschneider","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Van Abel","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology - Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida A.","family":"Postma","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands"},{"name":"Maastricht School for Mental Health and Sciences (MHeNs), Maastricht University, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M.","family":"Palm","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hoeben","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Department of Medical Oncology, GROW \u2013 School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Lydiatt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Creighton University, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal G.","family":"Patel","sequence":"additional","affiliation":[{"name":"Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin L. K.","family":"Chua","sequence":"additional","affiliation":[{"name":"National Cancer Centre Singapore and Duke-NUS Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"O\u2019Sullivan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"ooi250017r1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ijrobp.2019.03.047","article-title":"Radiologic extranodal extension portends worse outcome in cN+ TNM-8 stage I human papillomavirus-mediated oropharyngeal cancer.","volume":"104","author":"Billfalk-Kelly","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ooi250017r2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.radonc.2019.10.011","article-title":"Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.","volume":"144","author":"Huang","year":"2020","journal-title":"Radiother Oncol"},{"issue":"4","key":"ooi250017r3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.","volume":"17","author":"O\u2019Sullivan","year":"2016","journal-title":"Lancet Oncol"},{"key":"ooi250017r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2022.105716","article-title":"Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma.","volume":"125","author":"Chin","year":"2022","journal-title":"Oral Oncol"},{"key":"ooi250017r5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1200\/EDBK_320939","article-title":"Assessment criteria and clinical implications of extranodal extension in head and neck cancer.","volume":"41","author":"Huang","year":"2021","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"7","key":"ooi250017r6","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1016\/S1470-2045(24)00066-4","article-title":"Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations.","volume":"25","author":"Henson","year":"2024","journal-title":"Lancet Oncol"},{"issue":"11","key":"ooi250017r7","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/hed.27130","article-title":"Augmenting inter-rater concordance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma: a multicenter study.","volume":"44","author":"Hoebers","year":"2022","journal-title":"Head Neck"},{"issue":"22","key":"ooi250017r10","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.19.00463","article-title":"Phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human papillomavirus-associated oropharynx squamous cell carcinoma.","volume":"37","author":"Ma","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"ooi250017r11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data.","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"8","key":"ooi250017r12","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1200\/JCO.2014.58.6412","article-title":"Refining American Joint Committee on Cancer\/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.","volume":"33","author":"Huang","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"ooi250017r13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/hed.1087","article-title":"A comparison of published head and neck stage groupings in carcinomas of the oral cavity.","volume":"23","author":"Groome","year":"2001","journal-title":"Head Neck"},{"issue":"1","key":"ooi250017r14","first-page":"1014","article-title":"Refining evaluation methodology on TNM Stage System: assessment on HPV-related oropharyngeal cancer.","volume":"2","author":"Xu","year":"2015","journal-title":"Austin Biometrics Biostatistics"},{"issue":"6","key":"ooi250017r15","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/1097-0142(20010915)92:6<1484::AID-CNCR1473>3.0.CO;2-W","article-title":"A comparison of published head and neck stage groupings in carcinomas of the tonsillar region.","volume":"92","author":"Groome","year":"2001","journal-title":"Cancer"},{"issue":"6","key":"ooi250017r16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2022.0615","article-title":"Assessment of toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma: the ORATOR2 phase 2 randomized clinical trial.","volume":"8","author":"Palma","year":"2022","journal-title":"JAMA Oncol"},{"issue":"10","key":"ooi250017r17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1470-2045(19)30410-3","article-title":"Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.","volume":"20","author":"Nichols","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"ooi250017r18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group trial (E3311).","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"issue":"9","key":"ooi250017r19","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002).","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"ooi250017r20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.ejso.2020.09.005","article-title":"Lymph node extracapsular extension as a marker of aggressive phenotype: classification, prognosis and associated molecular biomarkers.","volume":"47","author":"Bhattacharya","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"ooi250017r21","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1038\/s41598-022-07794-0","article-title":"Differential expression of podoplanin in metastatic lymph node is associated with extranodal extension in oropharyngeal cancer.","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"key":"ooi250017r22","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105167","article-title":"Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma.","volume":"114","author":"Pilar","year":"2021","journal-title":"Oral Oncol"},{"issue":"4","key":"ooi250017r23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1177\/0194599820951176","article-title":"Prognostic significance of extranodal extension in HPV-mediated oropharyngeal carcinoma: a systematic review and meta-analysis.","volume":"164","author":"Benchetrit","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"10","key":"ooi250017r24","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/lary.30572","article-title":"Extranodal extension improves AJCC-8 accuracy in HPV+ oropharyngeal cancer in a high-risk population.","volume":"133","author":"Burruss","year":"2023","journal-title":"Laryngoscope"},{"key":"ooi250017r25","doi-asserted-by":"crossref","first-page":"E1452","DOI":"10.1002\/hed.24257","article-title":"Radiologic extranodal spread and matted nodes: important predictive factors for development of distant metastases in patients with high-risk head and neck cancer.","volume":"38","author":"de Bree","year":"2016","journal-title":"Head Neck"},{"issue":"8","key":"ooi250017r26","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.21.01961","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial.","volume":"40","author":"Nichols","year":"2022","journal-title":"J Clin Oncol"},{"issue":"3","key":"ooi250017r27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/hed.26951","article-title":"Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins.","volume":"44","author":"Fenlon","year":"2022","journal-title":"Head Neck"},{"issue":"8","key":"ooi250017r28","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1007\/s00330-020-07572-4","article-title":"Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer.","volume":"31","author":"Elsholtz","year":"2021","journal-title":"Eur Radiol"},{"issue":"6","key":"ooi250017r29","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2589-7500(23)00046-8","article-title":"Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial.","volume":"5","author":"Kann","year":"2023","journal-title":"Lancet Digit Health"},{"issue":"1","key":"ooi250017r30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2214\/AJR.15.15895","article-title":"How sure are you, doctor? a standardized lexicon to describe the radiologist\u2019s level of certainty.","volume":"207","author":"Panicek","year":"2016","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"ooi250017r31","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/hed.25842","article-title":"High-grade radiologic extra-nodal extension predicts distant metastasis in stage II nasopharyngeal carcinoma.","volume":"41","author":"Hu","year":"2019","journal-title":"Head Neck"},{"issue":"6","key":"ooi250017r32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.oraloncology.2013.02.010","article-title":"Can extranodal spread in head and neck cancer be detected on MR imaging.","volume":"49","author":"Lodder","year":"2013","journal-title":"Oral Oncol"},{"issue":"4","key":"ooi250017r33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ijrobp.2018.05.020","article-title":"Radiologic-pathologic correlation of extranodal extension in patients with squamous cell carcinoma of the oral cavity: implications for future editions of the TNM classification.","volume":"102","author":"Almulla","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ooi250017r34","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105625","article-title":"Correlation between radiographic and pathologic lymph node involvement and extranodal extension via CT and PET in HPV-associated oropharyngeal cancer.","volume":"123","author":"Kowalchuk","year":"2021","journal-title":"Oral Oncol"},{"issue":"10","key":"ooi250017r35","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/hed.27138","article-title":"Performance of the Neck Imaging Reporting and Data System as applied by general neuroradiologists to predict recurrence of head and neck cancers.","volume":"44","author":"Lee","year":"2022","journal-title":"Head Neck"},{"key":"ooi250017r8","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017","edition":"8th ed"},{"key":"ooi250017r9","volume-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2016","edition":"8th ed"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2833785\/jamaotolaryngology_huang_2025_oi_250017_1752092948.74747.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T15:00:40Z","timestamp":1752159640000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2833785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2025.0848","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}